World Hepatitis Summit 2022

The third WHS was held as a predominately virtual event in 2022, with a small in-person hub at the World Health Organization in Geneva, with the theme of “Achieving the elimination of viral hepatitis within evolving health systems”.  The programme introduced the new Global Health Sector Strategy (2022-2030) and explored topics across the cascade of care for hepatitis A, B, C, D and E, including barriers such as stigma and discrimination and innovations, like the potential for a functional cure for hepatitis B.

The summit had a broad reach, with over 750 delegates from 120 countries, including 28 Ministries of Health. Delegates had the opportunity to hear from 218 speakers from 63 countries, including WHO Director-General, Dr Tedros Adhanom Ghebreyesus, Helen Clark, the former Prime Minister of New Zealand and Daniel Ngamije, the Rwanda Minister of Health.

The summit had over 41 million social media impressions and proved to have a huge impact, with 92% of delegates finding the conference had a benefit to them or their organisation. 

2022 Statement:

Countries made a historic commitment to eliminate viral hepatitis by 2030 at the 2016 World Health Assembly. 

Theme:

Achieving the elimination of viral hepatitis within evolving health systems.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

The role of decentralised and community-led services in accelerating progress towards elimination.

Role of harm reduction.